|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.935 USD | +4.03% |
|
+1.84% | -2.76% |
| May. 14 | Cantor Fitzgerald Adjusts Price Target on Exagen to $7 From $5, Maintains Overweight Rating | MT |
| May. 13 | Exagen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Exagen Inc. updated earnings guidance for the full year 2024. For full year 2024 revenue, company is increasing guidance to at least $55 million.
| 1st Jan change | Capi. | |
|---|---|---|
| -2.76% | 33.62M | |
| +17.73% | 83.46B | |
| -32.08% | 67.33B | |
| -2.18% | 25.66B | |
| +3.56% | 17.91B | |
| -13.68% | 16.54B | |
| +0.75% | 15.43B | |
| +74.92% | 13.46B | |
| +73.16% | 12.78B | |
| -2.02% | 12.33B |
EXAGEN INC. 
